Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The antibody response to the glycan α‐Gal correlates with COVID‐19 disease symptoms, Antibodies to α-Gal and COVID-19

  • Urra, José Miguel
  • Ferreras-Colino, Elisa
  • Contreras, Marinela
  • Cabrera, Carmen M.
  • Fernández de Mera, Isabel G.
  • Villar, Margarita
  • Cabezas-Cruz, Alejandro
  • Gortázar, Christian
  • Fuente, José de la
Versión preprint disponible en: http://hdl.handle.net/10261/216781, The coronavirus disease 19 (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has affected millions of people worldwide. The characterization of the immunological mechanisms involved in disease symptomatology and protective response is important to advance in disease control and prevention. Humans evolved by losing the capacity to synthesize the glycan Galα1‐3Galβ1‐(3)4GlcNAc‐R (α‐Gal), which resulted in the development of a protective response against pathogenic viruses and other microorganisms containing this modification on membrane proteins mediated by anti‐α‐Gal IgM/IgG antibodies produced in response to bacterial microbiota. In addition to anti‐α‐Gal antibody‐mediated pathogen opsonization, this glycan induces various immune mechanisms that have shown protection in animal models against infectious diseases without inflammatory responses. In this study, we hypothesized that the immune response to α‐Gal may contribute to the control of COVID‐19. To address this hypothesis, we characterized the antibody response to α‐Gal in patients at different stages of COVID‐19 and in comparison with healthy control individuals. The results showed that while the inflammatory response and the anti‐SARS‐CoV‐2 (Spike) IgG antibody titers increased, reduction in anti‐α‐Gal IgE, IgM and IgG antibody titers and alteration of anti‐α‐Gal antibody isotype composition correlated with COVID‐19 severity. The results suggested that the inhibition of the α‐Gal‐induced immune response may translate into more aggressive viremia and severe disease inflammatory symptoms. These results support the proposal of developing interventions such as probiotics based on commensal bacteria with α‐Gal epitopes to modify the microbiota and increase the α‐Gal‐induced protective immune response and reduce the severity of COVID‐19., This work was partially supported by the Consejería de Educación, Cultura y Deportes, JCCM, Spain, project CCM17-PIC-036 (SBPLY/17/180501/000185). We acknowledge the University of Castilla La Mancha (UCLM, Spain) support to Grupo SaBio. MC was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain (grant FJC-2018-038277-I). IGFM was supported by the UCLM. MV was supported by the UCLM and the Fondo Europeo de Desarrollo Regional, FEDER, EU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Control of tick infestations in wild roe deer (Capreolus capreolus) vaccinated with the Q38 Subolesin/Akirin chimera

  • Contreras, Marinela
  • San José, Cristina
  • Estrada-Peña, Agustín
  • Talavera, Ventura
  • Rayas, Elena
  • León, Clara I.
  • Núñez, José Luis
  • Fernández de Mera, Isabel G.
  • Fuente, José de la
Ticks (Acari: Ixodidae) are considered to be the most important vectors of disease-causing pathogens in domestic and wild animals, and emerging and re-emerging tick-borne diseases (TBD) exert an enormous impact on them. Wild ungulates are hosts for a wide variety of tick species and tick-borne pathogens that affect human and animal health. Consequently, the control of tick infestations and tick-borne pathogen prevalence is essential in some regions. Acaricides and animal management or culling have been used for the control of tick infestations and TBD, but tick vaccines constitute the best alternative to reduce the impact of acaricides on tick resistance and the environment. Previous results of controlled vaccination trials have shown that the Q38 Subolesin/Akirin chimera containing conserved protective epitopes could be a candidate universal antigen to control multiple tick species infestations. Thus, vaccination trials are necessary to validate these results under field conditions. In this study, we characterized the effect of Q38 vaccine on a wild population of European roe deer (Capreolus capreolus) in the Andalusian roe deer Reference Station (Junta de Andalucía, Cádiz, Spain). In this location, roe deer suffer especially severe parasitic conditions in some periods and commercial pesticides and ixodicides that are authorized to control ticks without specificity are frequently applied in the field, posing a threat to the environment. Animals vaccinated over a three-year period showed an antibody response to the vaccine antigen and a reduction in tick infestations by multiple species including Hyalomma marginatum, H. lusitanicum, Rhipicephalus bursa and Ixodes ricinus previously identified in roe deer, when compared to untreated controls. These results suggest the efficacy of Q38 for the control of tick infestations in wildlife., This research has been developed within the agreement of collaboration between SaBio (Animal health and Biotechnology) from IREC (Instituto de Investigación en Recursos Cinegéticos) and Agencia de Medio Ambiente y Agua de Andalucía (Consejería de Agricultura, Ganadería, Pesca y Desarrollo Sostenible-Junta de Andalucía. Marinela Contreras is funded by the Ministerio de Ciencia, Innovación y Universidades, Spain, grant FJC-2018-038277-I., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

What is the impact of the antibody response to glycan Alpha-Gal in Guillain-Barré syndrome associated with SARS-CoV-2 infection?

  • Doncel-Pérez, Ernesto
  • Contreras, Marinela
  • Gómez Hernando, Cesar
  • Vargas Baquero, Eduardo
  • Blanco García, Javier
  • Rodríguez Gómez, Javier
  • Velayos Galán, Alberto
  • Cabezas-Cruz, Alejandro
  • Gortázar, Christian
  • Fuente, José de la
There are several reports of the onset of Guillain-Barré syndrome (GBS) symptoms in COVID-19 patients. Previously, we reported that reduction in anti-α-Gal IgE, IgM and IgG antibody titers and alteration of anti-α-Gal antibody isotype composition correlated with COVID-19 severity. In this case study, we aimed to compare the anti-α-Gal antibody response in COVID-19 and GBS patients. The levels of anti-α-Gal IgE, IgM, IgG and IgA were measured by ELISA in the sera of GBS and COVID-19 patients. Patients diagnosed with GBS showed an increase in anti-α-Gal IgM when compared to healthy individuals and COVID-19 patients. The levels of anti-α-Gal IgA were significantly higher in COVID-19 patients. No significant differences were observed in the levels of IgE and IgG between GBS and COVID-19 patients. Profile of anti-α-Gal antibody isotypes revealed a higher representation of anti-α-Gal IgM and IgG among GBS and COVID-19 patients, respectively. Remarkably, anti-α-Gal IgM was also highly represented in SARS-CoV-2 positive patients suffering GBS. Despite the limited number of cases included in the study, we suggest that anti-α-Gal IgM and IgA responses are differentially regulated in GBS and COVID-19 patients, which could reflect the disparate etiologies of these diseases. A possible association between high anti-α-Gal IgA in GBS and COVID-19 severity is proposed., This study was partially funded by the Consejería de Educación, Cultura y Deportes, JCCM, Spain, project CCM17-PIC-036 (SBPLY/17/180501/000185). MC was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain (grant FJC-2018-038277-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A review of constraints and solutions for collecting raptor samples and contextual data for a European Raptor Biomonitoring Facility

  • Dulsat-Masvidal, María
  • Lourenço, Rui
  • Lacorte Bruguera, Silvia
  • D'Amico, Marcello
  • Albayrak, Tamer
  • Andevski, Jovan
  • Aradis, Arianna
  • Baltag, Emanuel
  • Berger-Tal, Oded
  • Berny, Philippe
  • Choresh, Yael
  • Duke, Guy
  • Espín, Silvia
  • García-Fernández, Antonio J.
  • Gómez-Ramírez, Pilar
  • Hallgrimsson, Gunnar T.
  • Jaspers, Veerle L. B.
  • Johansson, Ulf
  • Wernham, Chris
The COST Action ‘European Raptor Biomonitoring Facility’ (ERBFacility) aims to develop pan-European raptor biomonitoring in support of better chemicals management in Europe, using raptors as sentinel species. This presents a significant challenge involving a range of constraints that must be identified and addressed. The aims of this study were to: (1) carry out a comprehensive review of the constraints that may limit the gathering in the field of raptor samples and contextual data, and assess their relative importance across Europe; and (2) identify and discuss possible solutions to the key constraints that were identified. We applied a participatory approach to identify constraints and to discuss feasible solutions. Thirty-one constraints were identified, which were divided into four categories: legal, methodological, spatial coverage, and skills constraints. To assess the importance of the constraints and their possible solutions, we collected information through scientific workshops and by distributing a questionnaire to stakeholders in all the countries involved in ERBFacility. We obtained 74 answers to the questionnaire, from 24 of the 39 COST participating countries. The most important constraints identified were related to the collection of complex contextual data about sources of contamination, and the low number of existing raptor population national/regional monitoring schemes and ecological studies that could provide raptor samples. Legal constraints, such as permits to allow the collection of invasive samples, and skills constraints, such as the lack of expertise to practice necropsies, were also highlighted. Here, we present solutions for all the constraints identified, thus suggesting the feasibility of establishing a long-term European Raptor Sampling Programme as a key element of the planned European Raptor Biomonitoring Facility., This paper is based on work from COST Action European Raptor Biomonitoring Facility (COST Action CA16224) supported by COST (European Cooperation in Science and Technology), including a grant for a short-term scientific mission awarded to the lead author. COST is funded by the Horizon 2020 Framework Programme of the European Union. Silvia Espín was financially supported by Ministerio de Ciencia, Innovación y Universidades (Juan de la Cierva-Incorporación postdoctoral contract, IJCI-2017-34653)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterization by quantitative serum proteomics of immune-related prognostic biomarkers for COVID-19 symptomatology

  • Villar, Margarita
  • Urra, José Miguel
  • Rodríguez del‐Río, Francisco J.
  • Artigas-Jerónimo, Sara
  • Jiménez-Collados, Natalia
  • Ferreras-Colino, Elisa
  • Contreras, Marinela
  • Fernández de Mera, Isabel G.
  • Estrada-Peña, Agustín
  • Gortázar, Christian
  • Fuente, José de la
The COVID-19 pandemic caused by SARS-CoV-2 challenges the understanding of factors affecting disease progression and severity. The identification of prognostic biomarkers and physiological processes associated with disease symptoms is relevant for the development of new diagnostic and therapeutic interventions to contribute to the control of this pandemic. To address this challenge, in this study, we used a quantitative proteomics together with multiple data analysis algorithms to characterize serum protein profiles in five cohorts from healthy to SARS-CoV-2-infected recovered (hospital discharge), nonsevere (hospitalized), and severe [at the intensive care unit (ICU)] cases with increasing systemic inflammation in comparison with healthy individuals sampled prior to the COVID-19 pandemic. The results showed significantly dysregulated proteins and associated biological processes and disorders associated to COVID-19. These results corroborated previous findings in COVID-19 studies and highlighted how the representation of dysregulated serum proteins and associated BPs increases with COVID-19 disease symptomatology from asymptomatic to severe cases. The analysis was then focused on novel disease processes and biomarkers that were correlated with disease symptomatology. To contribute to translational medicine, results corroborated the predictive value of selected immune-related biomarkers for disease recovery [Selenoprotein P (SELENOP) and Serum paraoxonase/arylesterase 1 (PON1)], severity [Carboxypeptidase B2 (CBP2)], and symptomatology [Pregnancy zone protein (PZP)] using protein-specific ELISA tests. Our results contributed to the characterization of SARS-CoV-2–host molecular interactions with potential contributions to the monitoring and control of this pandemic by using immune-related biomarkers associated with disease symptomatology., This research was partially funded by Junta de Comunidades de Castilla-La Mancha (JCCM), Spain and EU-FEDER (grants MYCOTRAINING SBPLY/19/180501/000174 and GALINFEC SBPLY/17/180501/000185). EF-C has a predoctoral grant from UCLM. MC was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain (grant FJC-2018-038277-I). IGF was supported by UCLM. MV was supported by UCLM and EU-FEDER., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cattle ticks and tick-borne diseases: a review of Uganda's situation

  • Kasaija, Paul D.
  • Estrada-Peña, Agustín
  • Contreras, Marinela
  • Kirunda, Halid
  • Fuente, José de la
Herein we review the epidemiology of ticks and tick-borne diseases (TTBDs), their impact on livestock health and on the economy, control and associated challenges in Uganda. Ticks are leading vectors of economically important pathogens and are widespread in Uganda due to suitable climatic conditions. Besides the physical injury inflicted on the animal host, ticks transmit a number of pathogens that can cause morbidity and mortality of livestock if untreated, resulting in economic losses. Uganda suffers an aggregated annual loss (direct and indirect) of over USD 1.1 billion in the TTBDs complex. East Coast fever (ECF) caused by a protozoan haemoparasite, Theileria parva, is the most prevalent and economically important tick-borne disease (TBD) in Uganda and its vector, the brown ear tick (Rhipicephalus appendiculatus) widely distributed. Other prevalent TBDs in Uganda include anaplasmosis, babesiosis and heartwater. We highlight the role of agro-ecological zones (AEZs) and livestock management system in the distribution of TTBDs, citing warm and humid lowlands as being ideal habitats for ticks and endemic for TBDs. Control of TTBDs is a matter of great importance as far as animal health is concerned in Uganda. Indigenous cattle, which make up over 90% of the national herd are known to be more tolerant to TTBDs and most farms rely on endemic stability to TBDs for control. However, exotic cattle breeds are more capital intensive than indigenous breeds, but the increasing adoption of tick-susceptible exotic cattle breeds (especially dairy) in western and central Uganda demands intensive use of acaricides for tick control and prevention of TBDs. Such acaricide pressure has unfortunately led to selection of acaricide-resistant tick populations and the consequent acaricide resistance observed in the field. Vaccination against ECF, selective breeding for tick resistance and integrated tick control approaches that limit tick exposure, could be adopted to interrupt spread of acaricide resistance. We recommend increasing monitoring and surveillance for TTBDs and for emerging acaricide resistance, improved extension services and sensitization of farmers on tick control measures, appropriate acaricide use and the development and implementation of vaccines for the control of TTBDs as more sustainable and effective interventions. A tick control policy should be developed, taking into account variations of agro-ecological zones, farm circumstances and indigenous technical knowledge, and this should be incorporated into the overall animal health program., This study was financially supported by the the National Agricultural Research Organization (NARO) of Uganda. MC was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain (grant FJC-2018-038277-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Changes in serum biomarkers of oxidative stress in cattle vaccinated with tick recombinant antigens: a pilot study

  • Contreras, Marinela
  • Peres Rubio, Camila
  • Fuente, José de la
  • Villar, Margarita
  • Merino, Octavio
  • Mosqueda, Juan
  • Cerón, José J.
This article belongs to the Special Issue Tick-Vaccine and Tick-Control., Tick vaccination is an environmentally friendly alternative for tick control, pathogen infection, and transmission. Tick vaccine protection is sometimes incomplete, which may be due to problems in the stability, conformation, and activity of antibodies. This might be related to oxidative stress, but more studies are needed about the possible relationships between oxidative stress and immune function. The objective of this study was to evaluate and compare various serum biomarkers of antioxidant response and oxidative damage in cattle vaccinated with two recombinant antigens, the chimera of Subolesin- BM95 (homologue antigen of BM86)-MSP1a and BM86, and a control consisting in the adjuvant of the vaccines. Cupric reducing antioxidant capacity (CUPRAC), ferric reducing ability of the plasma (FRAP), trolox equivalent antioxidant capacity (TEAC), total thiol concentrations, and uric acid were evaluated in serum to determine the antioxidant response. To evaluate oxidative status, ferrous oxidation-xylenol orange (FOX), total oxidant status (TOS), advanced oxidation protein products (AOPP) and hydrogen peroxide (H2O2) concentrations in serum were determined. In addition, correlations between biomarkers of oxidative stress and antibody titers were evaluated. A significant decrease in all antioxidant biomarkers, with exception of thiol, and also a decrease in the oxidant markers TOS, AOPP and H2O2 was observed in cattle vaccinated with BM86, that also showed the highest antibody titers response whereas no significant differences in any of the biomarkers were detected in the Subolesin-Bm95-MSP1a and control groups. In addition, the dynamics of Cuprac and H2O2 with time showed significant differences between the groups. Although this is a pilot study and the results should be interpreted with caution and corroborated by studies involving a large number of animals, our results indicate that, in our experimental conditions, those vaccines able to induce a lower oxidative stress produce a higher concentration of antigen-specific antibodies. Overall, the results of the study provided information on the behavior of different biomarkers related to antioxidant defense, and the oxidative damage in cattle in response to vaccination., This research was funded by Seneca Foundation-Regional Agency for Science and Technology of the Government of Murcia, Spain, grant number 19894/GERM/15 and Marinela Contreras is funded by the Ministerio de Ciencia, Innovación y Universidades, Spain, grant FJC-2018-038277-I., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterization of the anti-α-Gal antibody profile in association with Guillain-Barré syndrome, implications for tick-related allergic reactions

  • Pacheco, Iván
  • Fernández de Mera, Isabel G.
  • Feo Brito, Francisco
  • Gómez Torrijos, Elisa
  • Villar, Margarita
  • Contreras, Marinela
  • Lima-Barbero, José Francisco
  • Doncel-Pérez, Ernesto
  • Cabezas-Cruz, Alejandro
  • Gortázar, Christian
  • Fuente, José de la
Humans evolved by losing the capacity to synthesize the glycan Galα1-3Galβ1-(3)4GlcNAc-R (α-Gal), which resulted in the capacity to develop a protective response mediated by anti-α-Gal IgM/IgG antibodies against pathogens containing this modification on membrane proteins. As an evolutionary trade-off, humans can develop the alpha-Gal syndrome (AGS), a recently diagnosed disease mainly associated with allergic reactions to mammalian meat consumption. The etiology of the AGS is the exposure to tick bites and the IgE antibody response against α-Gal-containing glycoproteins and glycolipids. The objective of this study was to characterize the anti-α-Gal antibody response in association with the immune-mediated peripheral neuropathy, Guillain-Barré syndrome (GBS), and compare it with different factors known to modulate the antibody response to α-Gal such as exposure to tick bites and development of allergic reactions in response to tick bites. The results showed a significant decrease in the IgM/IgG response to α-Gal in GBS patients when compared to healthy individuals. In contrast, the IgM/IgG levels to α-Gal did not change in patients with allergic reactions to tick bites. The IgE response was not affected in GBS patients, but as expected, the IgE levels significantly increased in individuals exposed to tick bites and patients with tick-associated allergies. These results suggest that the immune pathways of anti-α-Gal IgM/IgG and IgE production are independent. Further studies should consider the susceptibility to allergic reactions to tick bites in GBS patients., This work was supported by the Consejería de Educación, Cultura y Deportes, JCCM, Spain, project CCM17-PIC-036 (SBPLY/17/180501/000185). MV was supported by the University of Castilla La Mancha (UCLM, Spain) and the Fondo Europeo de Desarrollo Regional, FEDER, EU. IGFM was supported by the UCLM. MC was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain (grant FJC-2018-038277-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Probiotic bacteria with high alpha-gal content protect Zebrafish against mycobacteriosis

  • Pacheco, Iván
  • Díaz-Sánchez, Sandra
  • Contreras, Marinela
  • Villar, Margarita
  • Cabezas-Cruz, Alejandro
  • Gortázar, Christian
  • Fuente, José de la
This article belongs to the Special Issue Zebrafish as a Powerful Tool for Drug Discovery 2021., Mycobacteriosis affects wild fish and aquaculture worldwide, and alternatives to antibiotics are needed for an effective and environmentally sound control of infectious diseases. Probiotics have shown beneficial effects on fish growth, nutrient metabolism, immune responses, disease prevention and control, and gut microbiota with higher water quality. However, the identification and characterization of the molecules and mechanisms associated with probiotics is a challenge that requires investigation. To address this challenge, herein we used the zebrafish model for the study of the efficacy and mechanisms of probiotic interventions against tuberculosis. First, bacteria from fish gut microbiota were identified with high content of the surface glycotope Galα1-3Galβ1-(3)4GlcNAc-R (α-Gal) that has been shown to induce protective immune responses. The results showed that probiotics of selected bacteria with high α-Gal content, namely Aeromonas veronii and Pseudomonas entomophila, were biosafe and effective for the control of Mycobacterium marinum. Protective mechanisms regulating immunity and metabolism activated in response to α-Gal and probiotics with high α-Gal content included modification of gut microbiota composition, B-cell maturation, anti-α-Gal antibodies-mediated control of mycobacteria, induced innate immune responses, beneficial effects on nutrient metabolism and reduced oxidative stress. These results support the potential of probiotics with high α-Gal content for the control of fish mycobacteriosis and suggested the possibility of exploring the development of combined probiotic treatments alone and in combination with α-Gal for the control of infectious diseases., This research was funded by Junta de Comunidades de Castilla-La Mancha (JCCM), Spain, and EU-FEDER (grant GALINFEC SBPLY/17/180501/000185). MC was funded by the Ministerio de Ciencia, Innovación y Universidades, Spain (grant FJC-2018-038277-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

A quantum vaccinomics approach based on protein-protein interactions

  • Contreras, Marinela
  • Artigas-Jerónimo, Sara
  • Pastor Comín, Juan J.
  • Fuente, José de la
Vaccines are the most effective preventive intervention to reduce the impact of infectious diseases worldwide. In particular, tick-borne diseases represent a growing burden for human and animal health worldwide and vaccines are the most effective and environmentally sound approach for the control of vector infestations and pathogen transmission. However, the development of effective vaccines for the control of tick-borne diseases with combined vector-derived and pathogen-derived antigens is one of the limitations for the development of effective vaccine formulations. Quantum biology arise from findings suggesting that living cells operate under non-trivial features of quantum mechanics, which has been proposed to be involved in DNA mutation biological process. Then, the electronic structure of the molecular interactions behind peptide immunogenicity led to quantum immunology and based on the definition of the photon as a quantum of light, the immune protective epitopes were proposed as the immunological quantum. Recently, a quantum vaccinomics approach was proposed based on the characterization of the immunological quantum to further advance the design of more effective and safe vaccines. In this chapter, we describe methods of the quantum vaccinomics approach based on proteins with key functions in cell interactome and regulome of vector–host–pathogen interactions for the identification by yeast two-hybrid screen and the characterization by in vitro protein–protein interactions and musical scores of protein interacting domains, and the characterization of conserved protective epitopes in protein interacting domains. These results can then be used for the design and production of chimeric protective antigens., This work was supported by the Ministerio de Economía, Industria y Competitividad (Spain) grant BFU2016-79892-P. Marinela Contreras is funded by the Ministerio de Ciencia, Innovación y Universidades, Spain, grant FJC-2018-038277-I. Sara Artigas-Jerónimo is supported by a predoctoral fellowship by the University of Castilla-La Mancha, UCLM, Spain., Peer reviewed